Approval · Notice of Compliance 1292 · 2000
AVELOX: Notice of Compliance 1292
Issued October 19, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1292
- Date
- October 19, 2000
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antibacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AVELOX | 02242965 | Cancelled Post Market |
Medicinal ingredients
- MOXIFLOXACIN 400 MG per TAB